circEIF3K has been shown to promote CRC progression in patients and exerted an oncogenic role in animal and clinical studies by downregulating its downstream effector miR-214 to attenuate the invasion of hypoxia-mediated CRC cells and downregulate PD-L1 expression. Here, CD274 is linked to colorectal carcinoma.